Oral Administration of the GnRH Antagonist Acyline in Normal Men Part II: Multiple-dose Pharmacokinetics (Acyline-7/MER 104-02).

Trial Profile

Oral Administration of the GnRH Antagonist Acyline in Normal Men Part II: Multiple-dose Pharmacokinetics (Acyline-7/MER 104-02).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2011

At a glance

  • Drugs Acyline (Primary)
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Sep 2008 Actual end date (February 2008) added as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Actual start date changed from February 2008 to January 2008 as reported by Clinicaltrials.gov
    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top